Page last updated: 2024-11-06

tris(2-aminoethyl)amine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Tris(2-aminoethyl)amine, also known as TREN, is a tripodal tetramine ligand. It is commonly used in coordination chemistry due to its ability to form stable complexes with various metal ions. TREN has been extensively studied for its potential applications in various fields, including catalysis, medicine, and materials science. The synthesis of TREN typically involves the reaction of diethylenetriamine with formaldehyde and ammonia. In terms of effects, TREN complexes have shown promising activity in areas such as anticancer therapy, antimicrobial activity, and enzyme inhibition. The importance of TREN lies in its versatility as a ligand, enabling the formation of complexes with diverse properties. Its ability to bind metal ions with high affinity and selectivity has led to its use in a wide range of applications, including drug delivery, bioimaging, and sensing. The study of TREN is driven by its potential to address critical challenges in various fields, such as developing novel therapies, improving diagnostic techniques, and creating advanced materials.'

tris(2-aminoethyl)amine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID77731
CHEMBL ID19823
CHEBI ID30631
SCHEMBL ID33394
MeSH IDM0261257

Synonyms (67)

Synonym
3gy3qsg6h5 ,
1,2-ethanediamine, n1,n1-bis(2-aminoethyl)-
diethylenetriamine, 4-(2-aminoethyl)-
unii-3gy3qsg6h5
4-(2-aminoethyl)diethylene triamine
nitrilotris(ethylamine)
4-(2-aminoethyl)diethylenetriamine
n,n-bis(2-aminoethyl)ethylenediamine
beta,beta',beta''-triaminotriethylamine
tren hp
2,2',2''-triaminotris(ethylamine)
einecs 223-857-4
1,2-ethanediamine, n,n-bis(2-aminoethyl)-
tris(aminoethyl)amine
2,2',2''-nitrilotris(ethylamine)
tri(2-aminoethyl)amine
tren
tris(2-aminoethyl)amine
2,2',2''-triaminotriethylamine
CHEBI:30631 ,
n,n-bis(2-aminoethyl)ethane-1,2-diamine
n,n-bis(2-aminoethyl)-1,2-ethanediamine
4097-89-6
14350-52-8
1, 2-ethanediamine, n,n-bis(2-aminoethyl)-, trihydrochloride
diethylenetriamine, 4-(2-aminoethyl)-, trihydrochloride
n',n'-bis(2-aminoethyl)ethane-1,2-diamine
n~1~,n~1~-bis(2-aminoethyl)-1,2-ethanediamine
nsc100649
tris(2-aminoethyl)amine, 96%
NCIOPEN2_006762
CHEMBL19823
mbylvokeddqjdy-uhfffaoysa-
inchi=1/c6h18n4/c7-1-4-10(5-2-8)6-3-9/h1-9h2
2,2',2''-nitrilotriethylamine
taea
T1243
n',n'-bis(2-azanylethyl)ethane-1,2-diamine
A825374
AKOS006221191
nsc 100649
n(1),n(1)-bis(2-aminoethyl)-1,2-ethanediamine
BP-20437
FT-0635124
tris(2-aminoethyl)-amine
tris (2-aminoethyl)amine
tris-(2-aminoethyl)-amine
tris-(2-aminoethyl)amine
tris-(aminoethyl)amine
SCHEMBL33394
2,2',2'-nitrilotriethylamine
DTXSID4063296
tris (2-aminoethyl) amine
tris[2-aminoethyl]amine
tris(2-aminoethyl)amine, technical, >=90% (gc)
2,2',2'-triaminotriethylamine
mfcd00008177
n1,n1-bis(2-aminoethyl)ethane-1,2-diamine
E70306
Q7843931
STR10055
CS-W016352
n,n-bis-(2-amino-ethyl)-ethane-1,2-diamine
n,n,n-tris(2-aminoethyl)amine
n1,n1-bis(2-aminoethyl)-1,2-ethanediamine
nitrilotriethylamine
EN300-203190
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
tetramineAny polyamine that contains four amino groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID197832Binding constant for spermine binding to Ribonuclease S (RNA ase) by saturation curve method1999Bioorganic & medicinal chemistry letters, May-03, Volume: 9, Issue:9
Design and semisynthesis of spermine-sensitive Ribonuclease S'.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (61)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (8.20)18.2507
2000's20 (32.79)29.6817
2010's32 (52.46)24.3611
2020's4 (6.56)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 45.24

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index45.24 (24.57)
Research Supply Index4.13 (2.92)
Research Growth Index4.97 (4.65)
Search Engine Demand Index64.07 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (45.24)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.64%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other60 (98.36%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]